Related Experiment Video
Updated: May 9, 2026
10:39
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Which biomarkers are effective for identifying Th2-driven inflammation in asthma?
Zuzana Diamant1, Ellen Tufvesson, Leif Bjermer
1Institute for Clinical Science, Department of Respiratory Medicine and Allergology, Skane University Hospital, Lund University, Klinikgatan 18, S-221 85, Lund, Sweden, z.diamant@gems.demon.nl.
Current Allergy and Asthma Reports
|August 7, 2013
Summary
Asthma is a complex disease with distinct inflammatory profiles, such as T helper (Th)2-high and Th2-low. Identifying biomarkers for these asthma subphenotypes is crucial for developing targeted therapies and monitoring treatment effectiveness.
Area of Science:
- Pulmonology
- Immunology
- Pharmacology
Background:
- Asthma is recognized as a heterogeneous disease with diverse underlying molecular mechanisms.
- Inflammatory subsets, specifically T helper (Th)2-high and Th2-low, have been identified, influencing treatment response.
- Understanding these subphenotypes is critical for advancing personalized asthma management.
Purpose of the Study:
- To review existing and novel biomarkers associated with Th2-inflammation in asthma.
- To highlight the utility of these biomarkers in classifying asthma subphenotypes for clinical research.
- To discuss the application of biomarkers for monitoring treatment efficacy in targeted asthma therapies.
Main Methods:
- Literature review of studies identifying and validating biomarkers for asthma subphenotypes.
- Analysis of immunological and pathophysiological data differentiating Th2-high and Th2-low asthma.
- Evaluation of biomarker applicability in clinical trial design and patient stratification.
Main Results:
- Several biomarkers indicative of Th2-inflammation in asthma have been identified.
- These biomarkers allow for the classification of asthma into distinct subphenotypes.
- Biomarkers show potential for guiding and monitoring targeted therapeutic interventions.
Conclusions:
- Accurate classification of asthma subphenotypes using biomarkers is essential for effective targeted treatment.
- Biomarkers of Th2-inflammation are valuable tools for clinical studies and treatment monitoring in asthma.
- Further research into novel biomarkers will enhance personalized medicine approaches for asthma management.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.